STOCK TITAN
  1. Home
  2. Sec-filings
  3. UTHR
  4. [144] UNITED THERAPEUTICS Corp SEC Filing

United Therapeutics (UTHR) Form 144: 209,000 shares tied to option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

United Therapeutics Group filed a Form 144 reporting a proposed sale of 209,000 shares of common stock, described as an exercise of stock options with a sale date of 07/01/2026. The filing lists an aggregate dollar figure of $113,242,470.00 on the same line. The reported sales in the excerpt also show multiple prior 10b5-1 plan sales by Martine Rothblatt of 9,500 shares on numerous dates in April–June 2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies the market of a planned resale subject to Rule 144 conditions.

Form 144 is a notice of an intended sale under resale exemptions; it does not itself execute a trade. The filing shows 209,000 shares connected to an option exercise with a stated sale date of 07/01/2026.

Cash‑flow treatment and final execution details are not provided in the excerpt; prior activity includes multiple 10b5-1 sales of 9,500 shares each during April–June 2026, suggesting planned, pre‑arranged disposals.

Shares reported for resale 209,000 shares listed with sale date <date>07/01/2026</date>
Aggregate dollar figure on line $113,242,470.00 appears on same line as the 209,000 share entry
Repeated 10b5-1 sale size 9,500 shares multiple 10b5-1 sales by Martine Rothblatt in Apr–Jun 2026
Listed sale method Exercise of Stock Options method associated with the 209,000 share line (07/01/2026)
Form 144 regulatory
"reported sale notification for 209,000 shares (07/01/2026)"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 regulatory
"multiple 10b5-1 Sales for MARTINE ROTHBLATT dated Apr–Jun 2026"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Securities To Be Sold line lists 'Exercise of Stock Options' for 07/01/2026"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does United Therapeutics' Form 144 show?

The Form 144 reports a proposed sale of 209,000 shares of common stock tied to an exercise of stock options with a sale date of 07/01/2026. It is a notification, not a confirmation of completed sale.

Who previously sold shares under a 10b5-1 plan in the excerpt?

The excerpt lists multiple 10b5-1 sales by Martine Rothblatt, each of 9,500 shares, with trades dated across April–June 2026, reflecting pre‑arranged dispositions rather than ad hoc open‑market timing.

Does the Form 144 indicate proceeds that the issuer will receive?

The filing line includes a dollar figure of $113,242,470.00 adjacent to the 209,000 share entry. The excerpt does not state who will receive proceeds or how cash will be treated in this transaction.

Is a Form 144 a trade confirmation for UTHR?

No. A Form 144 is a required notice for certain insider resales under Rule 144. It signals an intended resale but does not itself complete or confirm the execution of the sale.

What is the role of a 10b5-1 plan shown here?

A 10b5-1 plan provides a prearranged framework to sell shares at scheduled times. The excerpt shows many such sales of 9,500 shares, indicating systematic disposals under that plan during April–June 2026.